Culture

Potential drug for Alzheimer's disease prevention found safe and effective in animals

image: Compared with a control (left), treatment with the novel GSM (right) reduces the number of amyloid plaques (green) and proinflammatory cells called microglia (magenta) in the brains of mice carrying mutations linked to early-onset Alzheimer's disease.

Image: 
©2021 Rynearson et al. Originally published in <em>Journal of Experimental Medicine</em>. https://doi.org/10.1084/jem.20202560

Researchers at the University of California San Diego School of Medicine and Massachusetts General Hospital have identified a new drug that could prevent Alzheimer’s disease by modulating, rather than inhibiting, a key enzyme involved in forming amyloid plaques in the brain. The study, which will be published March 2 in the Journal of Experimental Medicine (JEM), demonstrates that the drug is safe and effective in rodents and monkeys, paving the way for future clinical trials in humans.

A key pathological hallmark of Alzheimer’s disease involves the formation of amyloid plaques composed of small protein fragments known as amyloid-β (Aβ) peptides. These peptides are generated by enzymes called β-secretase and γ-secretase, which sequentially cleave a protein called amyloid precursor protein on the surface of neurons to release Aβ fragments of varying lengths. Some of these fragments, such as Aβ42, are particularly prone to forming amyloid plaques, and their production is elevated in patients with mutations predisposing them to early-onset Alzheimer’s disease.

Several attempts have been made to treat or prevent Alzheimer’s disease using drugs that inhibit either β-secretase or γ-secretase. But many of these drugs have proved to be unsafe in humans, likely because β-secretase and γ-secretase are required to cleave additional proteins in the brain and other organs. A better approach could involve drugs known as γ-secretase modulators (GSMs), which, instead of inhibiting the γ-secretase enzyme, slightly alter its activity so that it produces fewer Aβ peptides that are prone to form plaques while continuing to cleave its other protein targets.

“GSMs therefore offer the ability to mitigate mechanism-based toxicities associated with γ-secretase inhibitors,” says Steven L. Wagner, PhD, a professor in the Department of Neurosciences at UC San Diego School of Medicine.

In the new study, Wagner and colleagues developed a novel GSM and tested it on mice, rats, and macaques. Repeated low doses of the drug completely eliminated Aβ42 production in mice and rats without causing any toxic side effects. The drug was also safe and effective in macaques, reducing Aβ42 levels by up to 70%.

The researchers then tested the drug in a mouse model of early-onset Alzheimer’s disease, treating the animals either before or shortly after they began to form amyloid plaques. In both cases, the novel GSM decreased plaque formation and reduced plaque-associated inflammation, which is thought to contribute to the development of disease.

This suggests that the drug could be used prophylactically to prevent Alzheimer’s disease, either in patients with genetic mutations that increase susceptibility to the disease or in cases where amyloid plaques have been detected by brain scans.

“In this study, we have pharmacologically characterized a potent GSM that, based on its preclinical attributes, appears to equal or exceed the potency of any previously tested GSMs,” adds Dr. Rudolph E. Tanzi, Professor of Neurology at Harvard and Massachusetts General Hospital. “Future clinical trials will determine whether this promising GSM is safe in humans and could be used to effectively treat or prevent Alzheimer’s disease.”

Credit: 
Rockefeller University Press

Drug seizures plummeted early in the COVID-19 pandemic, then climbed once lockdowns lifted

Law enforcement seizures of drugs, particularly marijuana and methamphetamine, dropped at the beginning of the COVID-19 pandemic, then increased significantly in the following months--exceeding pre-pandemic seizure rates and providing clues about the impact of the crisis on substance use, according to a new study in the journal Drug and Alcohol Dependence.

The research was conducted as part of the National Drug Early Warning System (NDEWS), which uses real-time surveillance to detect early signals of potential drug epidemics. NDEWS is led by a team of researchers at the University of Florida, New York University, and Florida Atlantic University, and is funded by the National Institute on Drug Abuse, part of the National Institutes of Health.

Early research about how the pandemic has affected patterns of substance use has yielded mixed results. Some sources suggest that overall drug use has increased, while others point to a drop in use and availability of certain drugs. During the same period, multiple studies show an increase in overdoses.

Given conflicting information about changes in drug use, availability, and overdoses after the onset of the COVID-19 pandemic, NDEWS researchers examined trends in drug seizures recorded in the National High Intensity Drug Trafficking Area Program's Performance Management Process database to gain additional insight as to how the pandemic and its associated restrictions have shifted drug use.

"Although seizure data is not the most robust indicator of the prevalence of drug use, it does serve as an indicator of drug supply and availability," said study author Joseph Palamar, PhD, MPH, an associate professor of population health at NYU Grossman School of Medicine, an affiliated researcher with the Center for Drug Use and HIV/HCV Research (CDUHR) at NYU School of Global Public Health, NDEWS co-investigator and chair of the NDEWS Scientific Advisory Group. "For example, fewer seizures, or lower volumes of drugs seized, can reflect a disruption of drug supply chains."

The researchers looked at trends in 29,574 seizures of marijuana, cocaine, methamphetamine, heroin, and fentanyl within five geographic areas: Washington/Baltimore, Chicago, Ohio, New Mexico, and North Florida. They examined the number and total weight of seizures from March 2019, a year before the pandemic began in the U.S., through September 2020, six months into the pandemic.

They detected a sharp decrease in drug seizures--particularly marijuana and methamphetamine--in March and April 2020, when stay-at-home orders were put into place across the country. After reaching a low point in April, the number of seizures then increased through the remainder of the spring and summer when social distancing measures became more relaxed, peaking in August 2020. The weight of drugs seized by law enforcement also significantly increased after April, driven by an increase in volume of marijuana seizures.

Notably, the August peaks in the number and volume of seizures for marijuana and methamphetamine were higher than a year earlier. However, it is unknown whether the peaks represent greater availability of the drugs or whether law enforcement officials were merely "catching up" after several months of delayed seizures.

The researchers did not detect significant shifts in seizures involving cocaine, heroin, or fentanyl during the early months of the COVID-19 pandemic, although seizures involving fentanyl slowly increased in a stable manner over the two years independent of the pandemic.

The study authors noted that more research is warranted to determine the extent to which these seizures reflect changes in drug use. While decreases in seizures, for instance, likely indicate lower availability, it is also possible that fewer seizures may have indicated less drug law enforcement activity during the early months of the pandemic.

"Future research should harmonize data on seizures with other studies of drug use, availability, and overdoses in order to determine the most accurate picture of drug use trends during the pandemic," added Linda B. Cottler, PhD, MPH, FACE, of the University of Florida and principal investigator of NDEWS.

Credit: 
New York University

Mammal ancestors moved in their own unique way

image: Photograph of a skeleton of the early non-mammalian synapsid (ancient mammal relative) Edaphosaurus on display at the Field Museum of Natural History.

Image: 
Photograph by Ken Angielczyk

The backbone is the Swiss Army Knife of mammal locomotion. It can function in all sorts of ways that allows living mammals to have remarkable diversity in their movements. They can run, swim, climb and fly all due, in part, to the extensive reorganization of their vertebral column, which occurred over roughly 320 million years of evolution.

Open any anatomy textbook and you'll find the long-standing hypothesis that the evolution of the mammal backbone, which is uniquely capable of sagittal (up and down) movements, evolved from a backbone that functioned similar to that of living reptiles, which move laterally (side-to-side). This so called "lateral-to-sagittal" transition was based entirely on superficial similarities between non-mammalian synapsids, the extinct forerunners of mammals, and modern-day lizards.

In a paper published on March 2 in Current Biology, a team of researchers led by Harvard University challenge the "lateral-to-sagittal" hypothesis by measuring vertebral shape across a broad sample of living and extinct amniotes (reptiles, mammals, and their extinct relatives). Using cutting-edge techniques they map the impact of evolutionary changes in shape on the function of the vertebral column and show that non-mammalian synapsids moved their backbone in a manner that was distinctly their own and quite different from any living animal.

The team, led by first author Katrina E. Jones, former Postdoctoral Researcher, Department of Organismic and Evolutionary Biology, Harvard University, found that while the degree of sagittal bending does increase during mammal evolution, the backbones of the earliest synapsids were optimized for stiffness and the evolutionary transition to mammals did not include a stage characterized by reptile-like lateral bending. Instead they discovered that modern lizards and other reptiles have a unique backbone morphology and function that does not represent ancestral locomotion, and that the earliest ancestors of mammals did not move like a lizard, as scientists previously posited.

"The long-held idea that there was a transition in mammal evolution directly from lateral to sagittal bending is far too simple, said Senior author Stephanie Pierce, Thomas D. Cabot Associate Professor in the Department of Organismic and Evolutionary Biology and curator of vertebrate paleontology in the Museum of Comparative Zoology at Harvard University. "Lizards and mammals diverged from one another millions of years ago and they've each gone on their own evolutionary journey. We show that living lizards don't represent any sort of ancestral morphology or function that the two groups would have had in common so long ago."

Co-author Ken Angielczyk, MacArthur Curator of Paleomammalogy, Negaunee Integrative Research Center, Field Museum of Natural History, agreed, "Reptiles have been evolving just as long as mammals and because of that there's just as much time for changes and specializations to accumulate for reptiles. If you look at the vertebrae of a modern lizard or crocodile their vertebrae are actually very different from early ancestors of mammals and reptiles that lived at the same time around 300 million years ago. Both living mammals and reptiles have accumulated their own set of specializations over evolutionary time."

Jones and co-authors, including former Harvard graduate student Blake Dickson, PhD '20, began by measuring the shape of the vertebrae of a range of reptiles, mammals, salamanders, and some fossil non-mammalian synapsids. The specimens came from museum collections all over the world, with modern animal skeletons primarily from the Museum of Comparative Zoology (MCZ), and fossil synapsids from the MCZ, the Field Museum of Natural History, and various other museums in the USA, Europe, and South Africa.

"We first had to quantify the shape of the vertebrae and that's actually a little bit tricky," said Jones. "Each vertebral column is made up of multiple vertebrae and when you have different numbers of vertebrae their shapes and functions might divide up in different ways."

They selected five vertebrae at equivalent locations from each of the vertebral columns and measured their shapes across the different animals in three-dimension. The results showed quantitatively that non-mammalian synapsid vertebrae are very different from the vertebrae of modern mammals, and critically also from the vertebrae of lizards and other reptiles.

Next, the researchers examined how the vertebrae may have functioned using data from their previous work that compared vertebral shape to degree of vertebral motion in living lizards and mammals, providing a crucial link between form and function. The data enabled the researchers to map variation in vertebral function across the broad sample of animals, including the fossils, which allowed them to reconstruct the precise combination of functional traits that described each group of animals.

"Our team's approach to data analysis is exciting as it can reveal how different backbone shapes may result in different functional tradeoffs," Pierce said. Reptiles, for example, are very good at lateral bending, but are unable to move their spine up-and-down like mammals. "In addition to lateral and sagittal bending we also examined other functions of the backbone and then determined the optimal combination of tradeoffs for mammals, reptiles, and non-mammalian synapsids," said Pierce.

"We were able to show that non-mammalian synapsids have a different combination of functions in their backbone to both living reptiles and mammals," Jones said, "and in the course of that evolution they weren't just traversing from the reptile-like lateral to the mammal-like sagittal bending, they were actually on a completely distinctive path in which they were evolving from a separate condition."

"The historical expectation is that the synapsid ancestors of mammals were making the same set of tradeoffs that modern reptiles do. But it turns out that they have an entirely different set of tradeoffs," Angielczyk said. "The expectation that reptiles would retain ancestral locomotor patterns that existed over 320 million years ago is too simple."

The results show the backbones of non-mammalian synapsids were actually quite stiff and completely unlike those of lizards which are very compliant in the lateral direction. Further, during the evolution of mammals, new functions were added to this stiff ancestral foundation, including sagittal bending in the posterior back and twisting up front. The addition of these new functions was pivotal in building the functionally diverse mammalian backbone, allowing modern-day mammals to run really fast and rotate their spine to groom their fur.

"By rigorously analyzing the fossil record, we are able to reject the simplistic lateral-to-sagittal hypothesis for a much more complex and interesting evolution story," Pierce said. "We are now revealing the evolutionary path towards the formation of the unique mammalian backbone."

The study is part of a series of ongoing projects on the evolution of the mammal backbone, piecing together its development, morphology, function, and evolution. "We still don't have the whole story," said Jones, "but we are getting close."

The researchers are now using three-dimensional modeling of the vertebrae to understand how the ancestors of mammals moved. "We are now testing our previous studies with CAD assisted three-dimensional models," said Jones. "So far it's working quite well and appears to support what we found in this paper."

Credit: 
Harvard University, Department of Organismic and Evolutionary Biology

Association between COVID-19 lockdown measures, ED visits for violence-related injuries in Wales

What The Study Did: This study investigates emergency department visits for violence-related injuries occurring at home and outside the home in Cardiff, Wales, before and after COVID-19 lockdown measures were instituted in March 2020.

Authors: Jonathan P. Shepherd, Ph.D., Crime and Security Research Institute at Cardiff University in Wales, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2020.25511)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Credit: 
JAMA Network

Belly fat resistant to every-other-day fasting: study

image: The mass spectrometer, a machine at the heart of proteomics, in the midst of analysing the sample. The image is a thermal photo of the front of the instrument that reaches 300oC during analysis.

Image: 
Mark Larance

In a mouse study, Australian researchers have mapped out what happens behind the scenes in fat tissue during intermittent fasting, showing that it triggers a cascade of dramatic changes, depending on the type of fat deposits and where they are located around the body.

Using state-of-the-art instruments, University of Sydney researchers discovered that fat around the stomach, which can accumulate into a 'protruding tummy' in humans, was found to go into 'preservation mode', adapting over time and becoming more resistant to weight loss.

The findings are published today in Cell Reports.

A research team led by Dr Mark Larance examined fat tissue types from different locations to understand their role during every-other-day fasting, where no food was consumed on alternate days.

The fat types where changes were found included visceral "belly" fat, which is fat tissue surrounding our organs including the stomach, and subcutaneous fat, which lies just under the skin and is associated with better metabolic health.

"While most people would think that all fat tissue is the same, in fact, the location makes a big difference," said senior author Dr Larance from the Charles Perkins Centre and School of Life and Environmental Sciences at the University of Sydney.

"Our data show both visceral and subcutaneous fat undergo dramatic changes during intermittent fasting," said Dr Larance, who is also a Cancer Institute of NSW Future Research Fellow.

Why visceral fat can be resistant to weight loss

During fasting, fat tissue provides energy to the rest of the body by releasing fatty acid molecules.

However, the researchers found visceral fat became resistant to this release of fatty acids during fasting.

There were also signs that visceral and subcutaneous fat increased their ability to store energy as fat, likely to rapidly rebuild the fat store before the next fasting period.

Dr Larance said it was possible that a history of repeated fasting periods triggered a preservation signalling pathway in visceral fat.

"This suggests the visceral fat can adapt to repeated fasting bouts and protect its energy store," he said.

"This type of adaptation may be the reason why visceral fat can be resistant to weight loss after long periods of dieting."

Dr Larance said using a mouse model was a useful analogue ahead of studies in humans.

"Mouse physiology is similar to humans, but their metabolism is much faster, allowing us to observe changes more rapidly than in human trials, and examine tissues difficult to sample in humans," he said.

Future research in mice and humans could uncover the mechanisms by which this resistance occurs and also which types of diet and other interventions may be best at tackling belly fat.

Mapping out the inner workings of fat deposits

The research team examined more than 8500 proteins located in fat deposits, creating a catalogue of changes that occurred during intermittent fasting, using a technique called proteomics.

Proteomics - the study of all proteins - a relatively new area of study that takes its name from genomics (the study of all genes), monitors how proteins react under certain conditions, which in this case is intermittent fasting.

The results provide a rich source of data that helps to paint a more complete picture of the inner workings of fat tissue.

It was via proteomics that the research team were alerted of major cellular changes caused by intermittent fasting and, after further analysis, highlighted the visceral fat's preservation mechanism in action.

The study was conducted using the instruments of the Sydney Mass Spectrometry in the Charles Perkins Centre, part of the University of Sydney's Core Research Facilities.

Dr Larance says it should be noted that findings from the intermittent study may not apply to different diet regimes such as the 5:2 diet (fasting 2 days out of 7) or calorie restriction, which is common in people wanting to lose weight.

The results lay the foundation for future studies, which will dissect the molecules responsible for why visceral fat is resistant to energy release during fasting, and help determine what diet plans would be most beneficial for metabolic health.

"This sort of research has been enabled by these new instruments that allow us to 'look beyond the streetlight' - it's hypothesis generating; we knew we would find something but we didn't know what," Dr Larance explained.

"Now that we've shown 'belly fat' in mice is resistant to this diet, the big question will be to answer why, and how do we best tackle it?"

Credit: 
University of Sydney

Assessment of hotel-based COVID-19 isolation, quarantine strategy for people experiencing homelessness

What The Study Did: This study suggests that, during the COVID-19 pandemic, a hotel- based isolation and quarantine strategy that delivers integrated medical and behavioral health support to people experiencing homelessness can be done safely outside the hospital setting.

Authors: Jonathan D. Fuchs, M.D., M.P.H., of the San Francisco Department of Public Health, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2021.0490)

Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Credit: 
JAMA Network

Requests for brand name over generic prescription drugs cost the Medicare program $1.7 billion in a single year, study finds

The Medicare Part D program would have saved $977 million in a single year if all branded prescription drugs requested by prescribing clinicians had been substituted by a generic option, according to a new study by researchers at the Johns Hopkins Bloomberg School of Public Health. And if Medicare patients had requested generic drugs instead of brand name drugs, the Medicare Part D program would have saved an additional $673 million in one year, for a total savings of $1.7 billion.

Medicare Part D offers supplemental outpatient drug coverage plans for seniors age 65 and older and people receiving disability benefits, and accounts for approximately one-third of total prescription drug spending in the U.S.

Despite laws in all 50 states and the District of Columbia promoting generic drug dispensing, the study found that in 2017 under the Medicare Part D program, prescribing clinicians and patients together requested brand name prescription drugs over generics 30 percent of the time when a brand name drug was dispensed.

Among the 169 million filled prescriptions analyzed in the study, 8.5 million involved dispensing a brand-name prescription drug when generics were available. Of these, 17 percent (1.4 million claims) involved the prescribing provider requesting a brand-name drug over a generic version and, in another 13.5 percent (1.1 million claims) patients requesting brand name drugs versus generic options.

The study will be published online March 2 in JAMA Network Open.

"Even with laws in place, requesting a brand name drug happens way more frequently than it should," says Gerard Anderson, PhD, professor in the Department of Health Policy and Management at the Bloomberg School. "This dispensing pattern results in exponentially higher costs for both the Medicare Part D program and patients."

For the study, the researchers analyzed Medicare Part D prescription drug claims from 2017. The analysis drew from a random sample representing 20 percent of Medicare beneficiaries and 224 drugs that had at least one generic substitute and at least 1,000 claims. The researchers analyzed information from each claim, including the type of drug dispensed, Medicare Part D spending, and the patient out-of-pocket spending.

Medicare patients would also benefit by paying less for prescriptions drugs. The study found that Medicare patients would have saved $161 million in 2017 if prescribing providers had requested generic drugs over brand name options. In addition, Medicare patients would have also saved $109 million if patients had requested generic drugs over brand name options. In all, Medicare patients spent $270 million more than necessary for prescriptions drugs in the year studied.

While branded prescription drug dispensing accounts for only 5 percent of Medicare Part D drug claims when both brand and generic drugs are available, these findings underscore how costly brand name drugs are to Medicare beneficiaries and the Medicare program.

Recent research has found that skepticism about generic medications is common among clinicians and patients. Surveys have found that more than one-third of patients reported a preference for branded products to generics, and 46 percent of patients asked their provider to prescribe a brand name drug over a generic.

The study also found that in 2017 the Medicare Part D program spent a total of $4.42 billion on brand name prescription drugs where no specific drug selection was indicated by a clinician or pharmacist. The authors recommend that the Medicare program look into these open-ended prescriptions, to see if it can reduce expenditures by encouraging opting for generic over brandname drugs when available.

The findings suggest that policies targeting both the clinician and the patient could have the greatest potential to promote generic drug use and therefore cost savings. Improving clinicians' perception of generic medication, raising awareness of the availability of generic drugs, and limiting direct pharmaceutical marketing can have substantial influence over the patients' medication preferences.

"Patients should always be mindful of the extra costs for themselves and for taxpayers associated with requesting a brand-name prescription drug," says Ge Bai, PhD, CPA, associate professor at the Johns Hopkins Carey Business School and in the Bloomberg School's Department of Health Policy and Management. "Prescribing clinicians can also play an important role in educating their patients on the safety and effectiveness of generic drugs."

Credit: 
Johns Hopkins Bloomberg School of Public Health

Meeting the meat needs of the future

image: Researchers at The University of Tokyo develop a method of culturing meat in the laboratory in the form of millimeter-scale contractile beef muscle that closely simulates steak meat

Image: 
Institute of Industrial Science, the University of Tokyo

Tokyo, Japan - Humans are largely omnivores, and meat in various forms has always featured in the diet of most cultures. However, with the increasing population and pressure on the environment, traditional methods of meeting this fundamental food requirement are likely to fall short. Now, researchers at the University of Tokyo report innovative biofabrication of bovine muscle tissue in the laboratory that may help meet escalating future demands for dietary meat.

With global urbanization, the economics of animal husbandry are becoming unsustainable. From an environmental viewpoint, the land and water costs of modern mega-scale livestock farming are untenable, as are the greenhouse gas emissions and the overall toll on the planet. Additionally, ethical concerns against inhuman exploitation of lower species for food are increasingly being voiced.

To address future requirements, tissue engineering of cultured meat is under development at several centers worldwide. However, most biosynthetic meat products are amorphous or granular-like minced meat, lacking the grain and texture of real animal flesh. Mai Furuhashi, lead author, explains their novel process. "Using techniques developed for regenerative medicine, we succeeded in culturing millimeter-sized chunks of meat wherein alignment of the myotubes help mimic the texture and mouthfeel of steak. For this, myoblasts drawn from commercial beef were cultured in hydrogel modules that could be stacked allowing fusion into larger chunks. We determined the optimal scaffolding and electrical stimulation to promote contractility and anatomical alignment of the muscle tissue to best simulate steak meat."

Lead author, Yuya Morimoto, describes the synthesized product. "Our morphological, functional and food feature analyses showed that the cultured muscle tissue holds promise as a credible steak substitute. Breaking force measurements showed that toughness approached that of natural beef over time. Significantly, microbial contamination was undetectable; this has implications for cleanliness, consumer acceptability and shelf-life."

"Our method paves the way for further development of larger portions of realistic cultured meat that can supplement or replace animal sources," claims Shoji Takeuchi, senior and corresponding author. "However, there is a long way to go before lab-grown meat is indistinguishable from the real thing and hurdles concerning consumer acceptance and cultural sensibilities are overcome. Nevertheless, this innovation promises to be a green and ethical alternative to animal slaughter in meeting our need for dietary meat."

Credit: 
Institute of Industrial Science, The University of Tokyo

Lead up to volcanic eruption in Galapagos captured in rare detail

image: Field crew downloading data from a continuously operating Global Positioning station in the Sierra Negra caldera, Galapagos Islands, Ecuador.

Image: 
Keith Williams (UMAVCO, Inc).

Hours before the 2018 eruption of Sierra Negra, the Galápagos Islands' largest volcano, an earthquake rumbled and raised the ground more than 6 feet in an instant. The event, which triggered the eruption, was captured in rare detail by an international team of scientists, who said it offers new insights into one of the world's most active volcanoes.

"The power of this study is that it's one of the first times we've been able to see a full eruptive cycle in this detail at almost any volcano," said Peter La Femina, associate professor of geosciences at Penn State. "We've monitored Sierra Negra from when it last erupted in 2005 through the 2018 eruption and beyond, and we have this beautiful record that's a rarity in itself."

For nearly two months in 2018, lava erupted from the volcano, covering about 19 square miles of Isabela Island, the largest island in the Galápagos and home to about 2,000 people and endangered animal species like the Galápagos giant tortoise.

"The 2018 eruption of Sierra Negra was a really spectacular volcanic event, occurring in the 'living laboratory' of the Galápagos Islands," said Andrew Bell, a volcanologist at the University of Edinburgh. "Great teamwork, and a bit of luck, allowed us to capture this unique dataset that provide us with important new understanding as to how these volcanoes behave, and how we might be able to better forecast future eruptions."

While Sierra Negra is among the world's most active volcanos, its remote location previously made monitoring difficult. Scientists now use networks of ground-based seismic and GPS monitoring stations and satellite observations to observe the volcano.

"Based on constant monitoring of activity of Galapagos volcanoes, we detected a dramatic increase of seismicity and a steady uplift of crater floor at Sierra Negra," said Mario Ruiz, director of the Ecuador Geophysical Institute, the country's national monitoring agency. "Soon we contacted colleagues from the United Kingdom, United States and Ireland and proposed them to work together to investigate the mechanisms leading to an impending eruption of this volcano. This research is an example of international collaboration and partnership."

The scientists captured data over 13 years as the volcano's magma chamber gradually refilled following the 2005 eruption, stressing the surrounding crust and creating earthquakes. This continued until June 2018, when an earthquake occurred on the calderas fault system and triggered the subsequent eruption, the scientists said.

"We have this story of magma coming in and stressing the system to the point of failure and the whole system draining again through the eruption of lava flows," La Femina said. "This is the first time anyone's seen that in the Galápagos to this detail. This is the first time we've had the data to say, 'okay, this is what happened here.'"

Often during volcanic eruptions, as magma chambers empty the ground above them sinks and forms a bowl-like depression, or a caldera. But Sierra Negra experienced a caldera resurgence, leaving this area higher in elevation than it was before the eruption, the scientists said.

Inside the Sierra Negra caldera is a "trap-door fault," which is hinged at one end while the other can be uplifted by rising magma. The scientists found the fault caused hills inside of the six-mile-wide caldera to lift vertically by more than 6 feet during the earthquake that triggered the eruption.

Caldera resurgence, important to better understanding eruptions, had not been previously observed in such detail, the scientists reported in the journal Nature Communications.

"Resurgence is typical of explosive calderas at volcanoes like Yellowstone, not the kind of shield volcanoes we see in the Galápagos or Hawaii," La Femina said. "This gives us the ability to look at other volcanoes in the Galápagos and say, 'well that's what could have happened to form that caldera or that resurgent ridge.'"

The scientists said the findings could help their counterparts in Ecuador better track unrest and warn of future eruptions.

"There are people who live on Isabella Island, so studying and understanding how these eruptions occur is important to manage the hazards and risks to local populations," La Femina said.

Credit: 
Penn State

New technology allows scientists first glimpse of intricate details of Little Foot's life

image: Little Foot Fossil skull in Diamond's beamline I12

Image: 
Copyright Diamond Light Source Ltd

In June 2019, an international team brought the complete skull of the 3.67-million-year-old Little Foot Australopithecus skeleton, from South Africa to the UK and achieved unprecedented imaging resolution of its bony structures and dentition in an X-ray synchrotron-based investigation at the UK's national synchrotron, Diamond Light Source. The X-ray work is highlighted in a new paper in e-Life, published today (2nd March 2021) focusing on the inner craniodental features of Little Foot. The remarkable completeness and great age of the Little Foot skeleton makes it a crucially important specimen in human origins research and a prime candidate for exploring human evolution through high-resolution virtual analysis.

To recover the smallest possible details from a fairly large and very fragile fossil, the team decided to image the skull using synchrotron X-ray micro computed tomography at the I12 beamline at Diamond, revealing new information about human evolution and origins. This paper outlines preliminary results of the X-ray synchrotron-based investigation of the dentition and bones of the skull (i.e., cranial vault and mandible).

Leading author and Principal Investigator, Dr Amelie Beaudet, Department of Archaeology, University of Cambridge and honorary research at the University of the Witwatersrand (Wits University) explains: "We had the unique opportunity to look at the finest details of the craniodental anatomy of the Little Foot skull. While scanning it, we did not know how well the smallest structures would be preserved in this individual, who lived more than 3.5 million years ago. So, when we were finally able to examine the images, we were all very excited and moved to see such intimate details of the life of Little Foot for the first time. The microstructures observed in the enamel indicate that Little Foot suffered through two clear periods of dietary stress or illness when she was a child."

The team were also able to observe and describe the vascular canals that are enclosed in the compact bone of the mandible. These structures have the potential to reveal a lot about the biomechanics of eating in this individual and its species, but also more broadly about how bone was remodelled in Little Foot The branching pattern of these canals indicates some remodelling took place, perhaps in response to changes in diet, and that Little Foot died as an older individual.

The team also observed tiny (i.e., less than 1 mm) channels in the braincase that are possibly involved in brain thermoregulation (i.e., how to cool down the brain). Brain size increased dramatically throughout human evolution (about threefold), and, because the brain is very sensitive to temperature change, understanding how temperature regulation evolves is of prime interest. Dr Amelie Beaudet adds: "Traditionally, none of these observations would have been possible without cutting the fossil into very thin slices, but with the application of synchrotron technology there is an exciting new field of virtual histology being developed to explore the fossils of our distant ancestors."

Dr Thomas Connolley, Principal Beamline Scientist at Diamond commented:
"Important aspects of early hominin biology remain debated, or simply unknown. In that context, synchrotron X-ray imaging techniques like microtomography have the potential to non-destructively reveal crucial details on the development, physiology, biomechanics and taxonomy of fossil specimens. Little Foot's skull was also scanned using the adjacent IMAT neutron instrument at ISIS Neutron and Muon Source, combining X-ray and neutron imaging techniques in one visit to the UK. With such a rich volume of information collected, we're eager to make more discoveries in the complementary X-ray and neutron tomography scans."

Applications of X-ray synchrotron-based analytical techniques in evolutionary studies have opened up new avenues in the field of (paleo)anthropology. In particular, X-ray synchrotron microtomography has proved to be enormously useful for observing the smallest anatomical structures in fossils that are traditionally only seen by slicing through the bones and looking at them under a microscope. Through the last decade, there have been more studies in palaeoanthropology using synchrotron radiation to investigate teeth and brain imprints in fossil hominins. However, scanning a complete skull such as the one of Little Foot and aiming to reveal very small details using a very high-resolution was quite challenging, but the team managed to develop a new protocol that made this possible. To recover the smallest possible details from a fairly large and very fragile fossil, the team decided to image the skull using synchrotron X-ray micro computed tomography at the I12 beamline at Diamond.

Principal Investigator, and Associate Professor, Prof Dominic Stratford, University of Witwatersrand (Wits University), School of Geography, Archaeology and Environmental Studies says: "This level of resolution is providing us with remarkably clear evidence of this individual's life. We think there will also be a hugely significant evolutionary aspect, as studying this fossil in this much detail will help us understand which species she evolved from and how she differs from others found at a similar time in Africa. This is just our first paper so watch this space. Funding permitting, we hope to be able to bring other parts of Little Foot to Diamond," adding:

"This research was about bringing the best-preserved Australopithecus skull to the best of the best synchrotron facility for our purposes. Traditionally, hominins have been analysed by measuring and describing by the exterior shapes of their fossilised bones to assess how these differ between species. Synchrotron development and microCT resources means that we are now able to virtually observe structures inside the fossils, which hold a wealth of information. More recently, technology has developed to such an extent that we can now virtually explore minute histological structures in three dimensions, opening new avenues for our research."

The first bones of the Little Foot fossil were discovered in the Sterkfontein Caves, northwest of Johannesburg, by Professor Ron Clarke of the University of the Witwatersrand in 1994. In 1997, following their discovery of the location of the skeleton, Professor Clarke and his team spent more than 20 years painstakingly removing the skeleton in stages from the concrete-like cave breccia using a small airscribe (a vibrating needle). Following cleaning and reconstructing, the skeleton was publicly unveiled in 2018. Wits University is the custodian of the StW 573, Little Foot, fossil.

Professor Ron Clarke, the British scientist based in South Africa who discovered and excavated Little Foot and conducted all the early examinations of the fossil, was also part of the research team and concludes: "It has taken us 23 years to get to this point. This is an exciting new chapter in Little Foot's history, and this is only the first paper resulting from her first trip out of Africa. We are constantly uncovering new information from the wealth of new data that was obtained. We hope this endeavour will lead to more funding to continue our work. Our team and PAST* emphasise that all of humanity has had a long-shared ancestry in harmony with the natural world, and that learning from those earliest ancestors gives us perspective on the necessity to conserve nature and our planet."

This paper is the first in what is expected to be a series of papers resulting from the wealth of data the Principal Investigators from the University of Witwatersrand in South Africa the University of Cambridge in UK, co-investigators from the Natural History Museum and Diamond were able to gain from their collaboration. Little Foot also underwent neutron imaging at STFC's ISIS Neutron and Muon Source at the same time as the work undertaken at Diamond Light Source, providing unprecedented access to complementary advanced imaging techniques. Neutrons are absorbed very differently from X-rays by the fossil's interior parts thanks to the sensitivity of neutrons to certain chemical elements. Despite having coarser spatial resolution, neutron tomography can sometimes differentiate between different mineralogical constituents for which contrast is very low for X-rays.

Credit: 
Diamond Light Source

Black NBA players have shorter careers than white players

COLUMBUS, Ohio - Black players in the NBA have 30% greater odds of leaving the league in any given season than white players who have equivalent performance on the court, a new study finds.

The results were driven mostly by bench players, who are the majority of those in the league, but who average less than 20 minutes of action per game.

These findings suggest that even in the NBA - a league in which Black players make up 70-75% of those on the court - African Americans face discrimination, said Davon Norris, lead author of the study and a doctoral student in sociology at The Ohio State University.

"If there is going to be anywhere in America where you would expect there wouldn't be racial disparities, it would be the NBA," Norris said.

"But even here we find there is an advantage to being white for most."

The disparity is not obvious if you look at raw data on career lengths, because Black and white players leave the league at similar rates, said study co-author Corey Moss-Pech, a PhD graduate of Ohio State who is now a postdoctoral research fellow in sociology at the University of Michigan.

"We see the effects when we account for performance," Moss-Pech said.

"Black players tend to be better than white players, according to the data. They should have longer careers, but they don't."

The study was published recently in the journal Social Forces.

The researchers analyzed the career lengths for all NBA players beginning their career in or after the 1979-80 season through the conclusion of the 2016-17 season.

The final sample included 2,611 players, who were considered for the purposes of the study as either Black, white or international.

The average career length in the NBA is only five years, Norris said, most likely because most players are cut by teams before they would choose to leave.

In the main analysis, the researchers evaluated performance using the same advanced metrics that NBA teams use, including player efficiency rating, offensive win shares and defensive win shares.

These measures combine stats like points scored, rebounds, steals and blocks into succinct comprehensive measures of performance.

They separated players into starters/key players (more than 30 minutes on the court per game), role players (between 20 and 30 minutes per game) and bench players (fewer than 20 minutes per game).

After taking on-court performance into account, there were "stark differences" in how long equally effective Black and white players stayed in the league.

For example, take the defensive win shares statistic, which measures the ability to prevent opposing teams from scoring. The researchers compared career length for white and Black players who were identical on this statistic, at the 50th percentile.

The proportion of white players at this level who left the league by their fifth season was 26%, significantly lower than the 33% of Black players who performed just as well but were no longer in the league after five years.

Not all in the NBA were treated similarly.

For those who were starters, there was no significant difference in career length based on race. For role players, Black players were at a disadvantage, but the difference was not large enough to be statistically significant.

However, there was a significant difference in bench players based on race, Norris said. About half of Black players and 65% of white players in the NBA are classified as bench players in this study.

"For those on the bench, being white really gives you an advantage," he said. "We have these cultural stereotypes that white men distinctly lack ability at basketball, but our analysis shows that this has little bearing on how long they last in the league."

The question becomes why. It doesn't appear to be associated with the race of the coach. The study found similar results whether there was a Black or white coach.

While the data in the study can't explain the disparity, Moss-Pech said, it may be that Black players are viewed differently from their white teammates off the court.

"Bench players may be more valued for their 'locker room presence' or for being a 'good teammate' than for their in-game performance. But concepts like 'good teammate' are likely racialized in a biased way that benefits white players," he said.

"White players may fit more comfortably into these team and organizational roles. We need more research that directly examines whether white and Black bench players are perceived differently in the media, by fans, by players or by decision makers."

The results have implications beyond the NBA, Norris said. They suggest that efforts to objectively measure employee effectiveness won't be enough to eliminate discrimination.

"NBA teams have all these stats available to measure productivity, and distinguish good from bad players, and yet we still see that disadvantages persist," he said.

"There are underlying structural and organizational processes at work that can undermine even the best efforts to objectively measure performance."

Credit: 
Ohio State University

Origin of life - The chicken-and-the-egg problem

A Ludwig-Maximilians-Universitaet (LMU) in Munich team has shown that slight alterations in transfer-RNA molecules (tRNAs) allow them to self-assemble into a functional unit that can replicate information exponentially. tRNAs are key elements in the evolution of early life-forms.

Life as we know it is based on a complex network of interactions, which take place at microscopic scales in biological cells, and involve thousands of distinct molecular species. In our bodies, one fundamental process is repeated countless times every day. In an operation known as replication, proteins duplicate the genetic information encoded in the DNA molecules stored in the cell nucleus - before distributing them equally to the two daughter cells during cell division. The information is then selectively copied ('transcribed') into what are called messenger RNA molecules (mRNAs), which direct the synthesis of the many different proteins required by the cell type concerned. A second type of RNA - transfer RNA (tRNA) - plays a central role in the 'translation' of mRNAs into proteins. Transfer RNAs act as intermediaries between mRNAs and proteins: they ensure that the amino-acid subunits of which each particular protein consists are put together in the sequence specified by the corresponding mRNA.

How could such a complex interplay between DNA replication and the translation of mRNAs into proteins have arisen when living systems first evolved on the early Earth? We have here a classical example of the chicken-and-the-egg problem: Proteins are required for transcription of the genetic information, but their synthesis itself depends on transcription.

LMU physicists led by Professor Dieter Braun have now demonstrated how this conundrum could have been resolved. They have shown that minor modifications in the structures of modern tRNA molecules permit them to autonomously interact to form a kind of replication module, which is capable of exponentially replicating information. This finding implies that tRNAs - the key intermediaries between transcription and translation in modern cells - could also have been the crucial link between replication and translation in the earliest living systems. It could therefore provide a neat solution to the question of which came first - genetic information or proteins?

Strikingly, in terms of their sequences and overall structure, tRNAs are highly conserved in all three domains of life, i.e. the unicellular Archaea and Bacteria (which lack a cell nucleus) and the Eukaryota (organisms whose cells contain a true nucleus). This fact in itself suggests that tRNAs are among the most ancient molecules in the biosphere.

Like the later steps in the evolution of life, the evolution of replication and translation - and the complex relationship between them - was not the result of a sudden single step. It is better understood as the culmination of an evolutionary journey. "Fundamental phenomena such as self-replication, autocatalysis, self-organization and compartmentalization are likely to have played important roles in these developments," says Dieter Braun. "And on a more general note, such physical and chemical processes are wholly dependent on the availability of environments that provide non-equilibrium conditions."

In their experiments, Braun and his colleagues used a set of reciprocally complementary DNA strands modeled on the characteristic form of modern tRNAs. Each was made up of two 'hairpins' (so called because each strand could partially pair with itself and form an elongated loop structure), separated by an informational sequence in the middle. Eight such strands can interact via complementary base-pairing to form a complex. Depending on the pairing patterns dictated by the central informational regions, this complex was able to encode a 4-digit binary code.

Each experiment began with a template - an informational structure made up of two types of the central informational sequences that define a binary sequence. This sequence dictated the form of the complementary molecule with which it can interact in the pool of available strands. The researchers went on to demonstrate that the templated binary structure can be repeatedly copied, i.e. amplified, by applying a repeating sequence of temperature fluctuations between warm and cold. "It is therefore conceivable that such a replication mechanism could have taken place on a hydrothermal microsystem on the early Earth," says Braun. In particular, aqueous solutions trapped in porous rocks on the seafloor would have provided a favorable environment for such reaction cycles, since natural temperature oscillations, generated by convection currents, are known to occur in such settings.

During the copying process, complementary strands (drawn from the pool of molecules) pair up with the informational segment of the template strands. In the course of time, the adjacent hairpins of these strands also pair up to form a stable backbone, and temperature oscillations continue to drive the amplification process. If the temperature is increased for a brief period, the template strands are separated from the newly formed replicate, and both can then serve as template strands in the next round of replication.

The team was able to show that the system is capable of exponential replication. This is an important finding, as it shows that the replication mechanism is particularly resistant to collapse owing to the accumulation of errors. The fact that the structure of the replicator complex itself resembles that of modern tRNAs suggests that early forms of tRNA could have participated in molecular replication processes, before tRNA molecules assumed their modern role in the translation of messenger RNA sequences into proteins. "This link between replication and translation in an early evolutionary scenario could provide a solution to the chicken-and-the-egg problem," says Alexandra Kühnlein. It could also account for the characteristic form of proto-tRNAs, and elucidate the role of tRNAs before they were co-opted for use in translation.

Laboratory research on the origin of life and the emergence of Darwinian evolution at the level of chemical polymers also has implications for the future of biotechnology. "Our investigations of early forms of molecular replication and our discovery of a link between replication and translation brings us a step closer to the reconstruction of the origin of life," Braun concludes.

Credit: 
Ludwig-Maximilians-Universität München

USC study shows promising potential for marine biofuel

image: Diver attaches kelp to an early prototype of the kelp elevator.

Image: 
Maurice Roper

For several years now, the biofuels that power cars, jet airplanes, ships and big trucks have come primarily from corn and other mass-produced farm crops. Researchers at USC, though, have looked to the ocean for what could be an even better biofuel crop: seaweed.

Scientists at the USC Wrigley Institute for Environmental Studies on Santa Catalina Island, working with private industry, report that a new aquaculture technique on the California coast dramatically increases kelp growth, yielding four times more biomass than natural processes. The technique employs a contraption called the "kelp elevator" that optimizes growth for the bronze-colored floating algae by raising and lowering it to different depths.

The team's newly published findings suggest it may be possible to use the open ocean to grow kelp crops for low-carbon biofuel similar to how land is used to harvest fuel feedstocks such as corn and sugarcane -- and with potentially fewer adverse environmental impacts.

The National Research Council has indicated that generating biofuels from feedstocks like corn and soybeans can increase water pollution. Farmers use pesticides and fertilizers on the crops that can end up polluting streams, rivers and lakes. Despite those well-evidenced drawbacks, 7% of the nation's transportation fuel still comes from major food crops. And nearly all of it is corn-based ethanol.

"Forging new pathways to make biofuel requires proving that new methods and feedstocks work. This experiment on the Southern California coast is an important step because it demonstrates kelp can be managed to maximize growth," said Diane Young Kim, corresponding author of the study, associate director of special projects at the USC Wrigley Institute and a professor of environmental studies at the USC Dornsife College of Letters, Arts and Sciences.

The study was published on Feb. 19 in the journal Renewable and Sustainable Energy Reviews. The authors include researchers from USC Dornsife, which is home to the Wrigley Institute, and the La Cañada, California-based company Marine BioEnergy, Inc., which designed and built the experimental system for the study and is currently designing the technology for open-ocean kelp farms.

Though not without obstacles, kelp shows serious promise as biofuel crop

Government and industry see promise in a new generation of climate-friendly biofuels to reduce net carbon dioxide emissions and dependence on foreign oil. New biofuels could either supplement or replace gasoline, diesel, jet fuel and natural gas.

If it lives up to its potential, kelp is a more attractive option than the usual biofuel crops -- corn, canola, soybeans and switchgrass -- for two very important reasons. For one, ocean crops do not compete for fresh water, agricultural land or artificial fertilizers. And secondly, ocean farming does not threaten important habitats when marginal land is brought into cultivation.

The scientists focused on giant kelp, Macrocystis pyrifera, the seaweed that forms majestic underwater forests along the California coast and elsewhere and washes onto beaches in dense mats. Kelp is one of nature's fastest-growing plants and its life cycle is well understood, making it amenable to cultivation.

But farming kelp requires overcoming a few obstacles. To thrive, kelp has to be anchored to a substrate and only grows in sun-soaked waters to about 60 feet deep. But in open oceans, the sunlit surface layer lacks nutrients available in deeper water.

To maximize growth in this ecosystem, the scientists had to figure out how to give kelp a foothold to hang onto, lots of sunlight and access to abundant nutrients. And they had to see if kelp could survive deeper below the surface. So, Marine BioEnergy invented the concept of depth-cycling the kelp, and USC Wrigley scientists conducted the biological and oceanographic trial.

The kelp elevator consists of fiberglass tubes and stainless-steel cables that support the kelp in the open ocean. Juvenile kelp is affixed to a horizontal beam, and the entire structure is raised and lowered in the water column using an automated winch.

Beginning in 2019, research divers collected kelp from the wild, affixed it to the kelp elevator and then deployed it off the northwest shore of Catalina Island, near Wrigley's marine field station. Every day for about 100 days, the elevator would raise the kelp to near the surface during the day so it could soak up sunlight, then lower it to about 260 feet at night so it could absorb nitrate and phosphate in the deeper water. Meantime, the researchers continually checked water conditions and temperature while comparing their kelp to control groups raised in natural conditions.

"We found that depth-cycled kelp grew much faster than the control group of kelp, producing four times the biomass production," Kim said.

The push to develop a new generation of biofuels

Prior to the experiment, it was unclear whether kelp could effectively absorb the nutrients in the deep, cold and dark environment. Nitrate is a big limiting factor for plants and algae, but the study suggests that the kelp found all it needed to thrive when lowered into deep water at night. Equally important, the kelp was able to withstand the greater underwater pressure.

Brian Wilcox, co-founder and chief engineer of Marine BioEnergy, said: "The good news is the farm system can be assembled from off-the-shelf products without new technology. Once implemented, depth-cycling farms could lead to a new way to produce affordable, carbon-neutral fuel year-round."

Cindy Wilcox, co-founder and president of Marine BioEnergy, estimates that it would take a Utah-sized patch of ocean to make enough kelp biofuel to replace 10% of the liquid petroleum consumed annually in the United States. One Utah would take up only 0.13% of the total Pacific Ocean.

Developing a new generation of biofuels has been a priority for California and the federal government. The U.S. Department of Energy's Advanced Research Projects Agency-Energy invested $22 million in efforts to increase marine feedstocks for biofuel production, including $2 million to conduct the kelp elevator study. The Department of Energy has a study to locate a billion tons of feedstock per year for biofuels; Cindy Wilcox of Marine BioEnergy said the ocean between California, Hawaii and Alaska could contribute to that goal, helping make the U.S. a leader in this new energy technology.

Credit: 
University of Southern California

Coronavirus-like particles could ensure reliability of simpler, faster COVID-19 tests

image: Coronavirus-like nanoparticles, made from plant viruses and bacteriophage, could serve as positive controls for the RT-LAMP test.

Image: 
Soo Khim Chan

Rapid COVID-19 tests are on the rise to deliver results faster to more people, and scientists need an easy, foolproof way to know that these tests work correctly and the results can be trusted. Nanoparticles that pass detection as the novel coronavirus could be just the ticket.

Such coronavirus-like nanoparticles, developed by nanoengineers at the University of California San Diego, would serve as something called a positive control for COVID-19 tests. Positive controls are samples that always test positive. They are run and analyzed right alongside patient samples to verify that COVID-19 tests are working consistently and as intended.

The positive controls developed at UC San Diego offer several advantages over the ones currently used in COVID-19 testing: they do not need to be kept cold; they are easy to manufacture; they can be included in the entire testing process from start to finish, just like a patient sample; and because they are not actual virus samples from COVID-19 patients, they do not pose a risk of infection to the people running the tests.

Researchers led by Nicole Steinmetz, a professor of nanoengineering at UC San Diego, published their work in the journal Biomacromolecules.

This work builds on an earlier version of the positive controls that Steinmetz's lab developed for the RT-PCR test, which is the gold standard for COVID-19 testing. The positive controls in the new study can be used not only for the RT-PCR test, but also for a cheaper, simpler and faster test called the RT-LAMP test, which can be done on the spot and provide results in about an hour.

Having a hardy tool to ensure these tests are running accurately--especially for low-tech diagnostic assays like the RT-LAMP--is critical, Steinmetz said. It could help enable rapid, mass testing of COVID-19 in low-resource, underserved areas and other places that do not have access to sophisticated testing equipment, specialized reagents and trained professionals.

Upgraded positive controls

The new positive controls are essentially tiny virus shells--made of either plant virus or bacteriophage--that house segments of coronavirus RNA inside. The RNA segments include binding sites for both of the primers used in the PCR and LAMP tests.

"This design creates an all-in-one control that can be used for either one of these assays, making it very versatile," said first author Soo Khim Chan, who is a postdoctoral researcher in Steinmetz's lab.

The team developed two types of positive controls. One was made from plant virus nanoparticles. To make them, the researchers infected cowpea plants in the lab with cowpea chlorotic mottle virus and then extracted the viruses from the plants. Afterwards, the researchers removed the virus' RNA and replaced it with a custom-made RNA template containing specific yet non-infectious sequences from the SARS-CoV-2 virus. The resulting nanoparticles consist of coronavirus RNA sequences packaged inside plant virus shells.

The other positive control was made from bacteriophage nanoparticles. It involved a similar recipe. The researchers infected E. coli bacteria with custom-made plasmids--rings of DNA--that contain specific fragments of sequences (which are also non-infectious) from the SARS-CoV-2 virus, as well as genes coding for surface proteins of a bacteriophage called Qbeta. This process caused the bacteria to produce nanoparticles that consist of coronavirus RNA sequences packaged inside bacteriophage shells.

The plant virus and bacteriophage shells are key to making these positive controls so sturdy. They protect the coronavirus RNA segments from breaking down at warmer temperatures--tests showed that they can be stored for a week at temperatures up to 40 C (104 F). The shells also protect the RNA during the first step of the PCR and LAMP tests, which involves breaking down cells in the sample--via enzymes or heat--to release their genetic material for testing.

These protections are not present in the positive controls currently used in COVID-19 testing (naked synthetic RNAs, plasmids or RNA samples from infected patients). That's why existing controls either require refrigeration (which makes them inconvenient to handle, costly to ship and store) or have to be added at a later stage of the test (which means that means scientists will not know if something went wrong in the first steps).

As a next step, the researchers are looking to partner up with industry to implement this technology. The positive controls can be adapted to any established RT-PCR or RT-LAMP assay, and using them would help negate false readouts, Steinmetz's team said. Plus, these positive controls can be easily produced in large quantities by molecular farming in plants or microbial culture fermentation, which is good news for translating them to large-scale manufacturing.

"With mutants and variants emerging, continued testing will be imperative to keep the population safe," Steinmetz said. "The new technology could find utility in particular for at-home tests, which may have a higher rate of false readouts due to the less controlled experimental conditions."

Credit: 
University of California - San Diego

'A Bluetooth mouse'--you can wirelessly read a mouse's mind

image: Mouse with a head-mounted Bluetooth wireless system that transmits neuronal signals from cortex implanted microneedle electrodes

Image: 
COPYRIGHT (C) TOYOHASHI UNIVERSITY OF TECHNOLOGY. ALL RIGHTS RESERVED.

Overview:

A research team at the Department of Electrical and Electronic Information Engineering, Department of Computer Science and Engineering, Department of Applied Chemistry and Life Science, and the Electronics-Inspired Interdisciplinary Research Institute (EIIRIS) at Toyohashi University of Technology has developed a lightweight, compact, Bluetooth-low-energy-based wireless neuronal recording system for use in mice. The wireless system weighs 3 with the battery, having advantages of high signal quality, good versatility, and low cost, compared to wired recording with a commercial neurophysiology system. The study was published online in Sensors and Actuators B: Chemical, on January 8, 2021.

Details:

Electrophysiological recording, which uses micro-scale needle-like electrodes penetrated into the brain tissue, has made significant contributions to fundamental neuroscience and medical applications. Electrophysiological recording, however, requires improvements in signal quality, invasiveness, and cable use. Although wireless recording can meet these requirements, conventional wireless systems are heavy and bulky for use in small animals such as mice, and systems based on their own custom technologies are costly and lack versatility.

The research team developed a lightweight, compact, wireless Bluetooth-low-energy neuronal recording system. As explained by the first author of the article, Ph.D. candidate Shinnosuke Idogawa, "We tackled the challenge of developing a lightweight and compact wireless neuronal recording system for use in mice and developed a 15 × 15 × 12 mm3 system weighing 3.9 g with the battery, which is less than 15% of a mouse's weight (e.g., 33 g for a two-week-old C57BL/6 mouse). Surprisingly, the wireless system demonstrates advantages of not only recording without using any cables, but also improvements in signal quality, including signal-to-noise ratios, compared to wired recording with a commercial neurophysiology system. In addition to these advantages, the developed wireless system costs USD $79.90, which is less than the wired system."

Development Background:

The leader of the research team, Associate Professor Takeshi Kawano said "We demonstrated the wireless system for single channel recording as our first step, but we can increase the channel numbers based on our system, and we are currently developing wireless systems for four-channels and more. Because we use Bluetooth technology, the device features will help us further develop small wireless neurophysiology systems with the advantages of good versatility and low cost for a wide range of users."

Future Outlook:

The research team believes that the wireless recording system can also be used to study the behavioral characteristics of mice as well as drug screening using mice. Because of its light weight, compactness, and Bluetooth technology, the developed wireless neuronal recording system can also be used with other species, including rats and monkeys.

Credit: 
Toyohashi University of Technology (TUT)